Kaelin R, Docquier C, Lew D, Carpentier N, Lambert P H, Waldvogel F A
Schweiz Med Wochenschr. 1978 Dec 9;108(49):1971-3.
Occurrence of immune complexes in malignant pleural effusions has been investigated by the 125I-c1q binding test. 55% of the pleural effusions had C1q binding activity levels higher than those found in transudates used as controls. The levels of C1q binding activity in effusions were significantly higher than those found in the serum of the same cancer patients. High levels of C1q binding activity were found in malignant effusion independently of type or differentiation of the tumors involved. The C1q binding material had properties of immune complexes. The levels of CH50 and C3d, i.e. the degradation product of C3, in malignant effusion were similar to those of transudates. These observations show a high incidence of immune complexes in malignant effusions and a slight activation of complement inadequate for its local consumption. The persistence in major quantity of immune complexes in malignant effusion suggests local formation or decreased clearance.
通过¹²⁵I-C1q结合试验对恶性胸腔积液中免疫复合物的发生情况进行了研究。55%的胸腔积液C1q结合活性水平高于用作对照的漏出液。积液中C1q结合活性水平显著高于同一癌症患者血清中的水平。在恶性胸腔积液中发现高水平的C1q结合活性,与所涉及肿瘤的类型或分化无关。C1q结合物质具有免疫复合物的特性。恶性胸腔积液中CH50和C3d(即C3的降解产物)水平与漏出液相似。这些观察结果表明恶性胸腔积液中免疫复合物的发生率很高,补体有轻微激活,但不足以在局部被消耗。恶性胸腔积液中大量免疫复合物的持续存在提示其在局部形成或清除减少。